Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Eton Pharmaceuticals (ETON) Gross Margin: 2019-2024

Historic Gross Margin for Eton Pharmaceuticals (ETON) over the last 6 years, with Dec 2024 value amounting to 60.01%.

  • Eton Pharmaceuticals' Gross Margin fell 2607.00% to 34.97% in Q3 2025 from the same period last year, while for Sep 2025 it was 65.88%, marking a year-over-year increase of 2991.00%. This contributed to the annual value of 60.01% for FY2024, which is 655.00% down from last year.
  • According to the latest figures from FY2024, Eton Pharmaceuticals' Gross Margin is 60.01%, which was down 9.84% from 66.56% recorded in FY2023.
  • Eton Pharmaceuticals' Gross Margin's 5-year high stood at 87.05% during FY2021, with a 5-year trough of -633.33% in FY2020.
  • Over the past 3 years, Eton Pharmaceuticals' median Gross Margin value was 66.56% (recorded in 2023), while the average stood at 64.65%.
  • In the last 5 years, Eton Pharmaceuticals' Gross Margin tumbled by 68,610bps in 2020 and then soared by 72,038bps in 2021.
  • Over the past 5 years, Eton Pharmaceuticals' Gross Margin (Yearly) stood at -633.33% in 2020, then soared by 72,038bps to 87.05% in 2021, then plummeted by 1,968bps to 67.38% in 2022, then crashed by 82bps to 66.56% in 2023, then plummeted by 655bps to 60.01% in 2024.